161 related articles for article (PubMed ID: 14612290)
1. Clinical significance of expression of p21 and p53 proteins and proliferating cell nuclear antigen in pancreatic cancer.
Dang CX; Han Y; Qin ZY; Wang YJ
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):302-5. PubMed ID: 14612290
[TBL] [Abstract][Full Text] [Related]
2. [Expression of p21(WAF1) and its relationship with p53 and PCNA protein in epithelial ovarian cancer].
Yan XJ; Liang LZ; Li DC; Li JL; Zhang CQ; Yuan SH
Ai Zheng; 2004 Jan; 23(1):74-80. PubMed ID: 14720380
[TBL] [Abstract][Full Text] [Related]
3. [Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior].
Ji SQ; Hua YW; Zhuang J; Gao Y; Kong Y; Han SL; Shao YF
Ai Zheng; 2002 Jun; 21(6):619-24. PubMed ID: 12452062
[TBL] [Abstract][Full Text] [Related]
4. Tumour suppressor protein (p53), apoptosis inhibiting protein (Bcl-2) and proliferating cell nuclear antigen (PCNA) expressions in a rat pancreatic tumour model.
Mäkinen K; Loimas S; Hakala T; Eskelinen M
Anticancer Res; 2007; 27(1A):23-6. PubMed ID: 17352211
[TBL] [Abstract][Full Text] [Related]
5. Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN).
Karamitopoulou E; Zlobec I; Tornillo L; Carafa V; Schaffner T; Brunner T; Borner M; Diamantis I; Zimmermann A; Terracciano L
Pathology; 2010 Apr; 42(3):229-34. PubMed ID: 20350215
[TBL] [Abstract][Full Text] [Related]
6. [Expressions of p53 and Gadd45a proteins in human pancreatic cancer and their clinicopathological significance].
Dong M; Zhou JP; Kong FM; Guo KJ; Tian YL; Dong YT
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):628-32. PubMed ID: 16274047
[TBL] [Abstract][Full Text] [Related]
7. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between expression of p57(kip2), cyclin E protein, PCNA, and clinicopathological factors in human pancreatic cancer].
Yue H; Zhang N; Feng XL; Ma SR; Song FL; Yang M; Tang YH
Ai Zheng; 2003 Jul; 22(7):705-9. PubMed ID: 12866960
[TBL] [Abstract][Full Text] [Related]
9. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing.
Lee JJ; Kuo MY; Cheng SJ; Chiang CP; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Apr; 99(4):471-8. PubMed ID: 15772596
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between expression of tumor suppressor protein p21 and p53 and cell proliferation in the gastric carcinoma].
Huang J; Gan J
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(5):441-3. PubMed ID: 10682555
[TBL] [Abstract][Full Text] [Related]
11. [Expression of P53 and PCNA in nasopharyngeal carcinoma and their relation with clinical stage, VCA/IgA, EA/IgA, radiation sensibility, and pognosis].
Mo HY; Zhang CQ; Feng KT; Zhang F; Hong MH; Sun ZY
Ai Zheng; 2004 Nov; 23(11 Suppl):1551-4. PubMed ID: 15566678
[TBL] [Abstract][Full Text] [Related]
12. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer.
Yoshimatsu T; Uramoto H; Oyama T; Yashima Y; Gu C; Morita M; Sugio K; Kohno K; Yasumoto K
Anticancer Res; 2005; 25(5):3437-43. PubMed ID: 16101161
[TBL] [Abstract][Full Text] [Related]
13. [Expression and significance of p53 and proliferating cell nuclear antigen in malignant tumor of maxillary sinus].
Xie RH; Chen ZH; Chen MY; Hou JH; Wu JH; Wu GH; Wu QL
Ai Zheng; 2002 Nov; 21(11):1244-7. PubMed ID: 12526226
[TBL] [Abstract][Full Text] [Related]
14. [A study of expression of p53, c-myc and PCNA in retinoblastoma].
Yang X; Zhang Z; Zeng Q
Zhonghua Yan Ke Za Zhi; 1999 Jul; 35(4):252-4, 14. PubMed ID: 11835814
[TBL] [Abstract][Full Text] [Related]
15. Expression of glucose transporter-1, hexokinase-II, proliferating cell nuclear antigen and survival of patients with pancreatic cancer.
Lyshchik A; Higashi T; Hara T; Nakamoto Y; Fujimoto K; Doi R; Imamura M; Saga T; Togashi K
Cancer Invest; 2007; 25(3):154-62. PubMed ID: 17530485
[TBL] [Abstract][Full Text] [Related]
16. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH
Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
[TBL] [Abstract][Full Text] [Related]
17. Disruption of p53-p21/WAF1 cell cycle pathway contributes to progression and worse clinical outcome of hepatocellular carcinoma.
Lee TK; Man K; Poon RT; Lo CM; Ng IO; Fan ST
Oncol Rep; 2004 Jul; 12(1):25-31. PubMed ID: 15201954
[TBL] [Abstract][Full Text] [Related]
18. Elevated p21 expression is associated with poor prognosis of rectal stromal tumors after resection.
Hu TH; Tai MH; Chuah SK; Chen HH; Lin JW; Huang HY; Chou YP; Yi LN; Kuo CM; Changchien CS
J Surg Oncol; 2008 Aug; 98(2):117-23. PubMed ID: 18521824
[TBL] [Abstract][Full Text] [Related]
19. [The significance of p21 expression in gastric cancer].
Aoyagi K; Koufuji K; Kodama I; Yano S; Ohta J; Takamiya H; Mizutani K; Murakami N; Takeda J; Shirouzu K; Nakashima A
Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():285-91. PubMed ID: 9263517
[TBL] [Abstract][Full Text] [Related]
20. Correlation between proliferating cell nuclear antigen and p53 protein expression and 5-year survival rate in nasopharyngeal carcinoma.
Wang LF; Chai CY; Kuo WR; Tai CF; Lee KW; Ho KY
Am J Otolaryngol; 2006; 27(2):101-5. PubMed ID: 16500472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]